BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IDEF Educational Series - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://idefeducationalseries.com
X-WR-CALDESC:Events for IDEF Educational Series
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250929T190000
DTEND;TZID=UTC:20250929T200000
DTSTAMP:20260815T062616
CREATED:20250827T164154Z
LAST-MODIFIED:20250827T164154Z
UID:1673-1759172400-1759176000@idefeducationalseries.com
SUMMARY:A Joint Approach to Psoriatic Disease Management: Bimzelx for your patients with PSO & PSA
DESCRIPTION:Speakers: Evan Siegel MD\, FACP\, MACR Senior Partner\, Arthritis and Rheumatism Associates Clinical Professor of Medicine Georgetown University School of Medicine Ben Lockshin MD\, FAAD Board‑Certified Dermatologist\, U.S. Dermatology Partners Director\, Clinical Trials Center at U.S. Dermatology Partners\n\n\n\nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY\n\nPlease join us for our next IDEF Educational Series Webinar: A Joint Approach to Psoriatic Disease Management: Bimzelx for your patients with PSO & PSA.\n\nCLICK HERE TO REGISTER
URL:https://idefeducationalseries.com/event/a-joint-approach-to-psoriatic-disease-management-bimzelx-for-your-patients-with-pso-psa/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250925T200000
DTEND;TZID=UTC:20250925T210000
DTSTAMP:20260815T062616
CREATED:20250823T143243Z
LAST-MODIFIED:20250823T143243Z
UID:1671-1758830400-1758834000@idefeducationalseries.com
SUMMARY:Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway
DESCRIPTION:Speaker: Douglas Kress\, MD Chief of the Division of Pediatric Dermatology UPMC Children’s Hospital of Pittsburgh \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nJoin us for another International Dermatology Education Foundation Series Webinar: Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review the evolving understanding of atopic dermatitis (AD)\, diagnosis\, management\, and the patient journey – Evaluate a treatment option for mild to moderate AD – Understand the indicated patient population for treatment \nCLICK HERE TO REGISTER \n 
URL:https://idefeducationalseries.com/event/mild-to-moderate-atopic-dermatitis-burden-of-disease-and-a-topical-pathway/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250924T190000
DTEND;TZID=UTC:20250924T200000
DTSTAMP:20260815T062616
CREATED:20250916T012205Z
LAST-MODIFIED:20250916T012205Z
UID:1677-1758740400-1758744000@idefeducationalseries.com
SUMMARY:A Breakthrough for Hands That Need to Get UP and GO Introducing ANZUPGO®
DESCRIPTION:Speaker: Lindsay Ackerman\, MD President Medical Dermatology Specialists Phoenix\, AZ\n\n\n\nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY\n\nPlease join us for our next IDEF Educational Series Webinar: A Breakthrough for Hands That Need to Get UP and GO Introducing ANZUPGO®: The FIRST and ONLY FDA-Approved Treatment for Moderate to Severe CHE\n\nREGISTER HERE
URL:https://idefeducationalseries.com/event/a-breakthrough-for-hands-that-need-to-get-up-and-go-introducing-anzupgo/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250923T190000
DTEND;TZID=UTC:20250923T200000
DTSTAMP:20260815T062616
CREATED:20250916T012011Z
LAST-MODIFIED:20250916T012011Z
UID:1675-1758654000-1758657600@idefeducationalseries.com
SUMMARY:Clearly Target RAR-y and the Lasting Marks of Acne
DESCRIPTION:Speaker: David Cotter\, MD\, PhD Dermatologist\, Las Vegas Dermatology Las Vegas\, Nevada Medical Director\, Lakes Dermatology Fellow\, American Academy of Dermatology \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Clearly Target RAR-y and the Lasting Marks of Acne. This presentation reviews the physical and emotional burdens of acne\, acne scarring\, and acne-induced hyperpigmentation. It highlights the unique and selective targeting of RAR-γ and reviews robust clinical data of this therapeutic approach\, while showcasing before and after images of successful patient outcomes. \nREGISTER HERE
URL:https://idefeducationalseries.com/event/clearly-target-rar-y-and-the-lasting-marks-of-acne-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250902T190000
DTEND;TZID=UTC:20250902T200000
DTSTAMP:20260815T062616
CREATED:20250813T185622Z
LAST-MODIFIED:20250823T143400Z
UID:1649-1756839600-1756843200@idefeducationalseries.com
SUMMARY:Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
DESCRIPTION:Speaker: Jeffrey LaDuca\, MD Founder Reflections Dermatology and Psoriasis Center New York\, New York Dr. LaDuca earned his undergraduate degree in biology from LeMoyne College in Syracuse\, NY. After beginning his graduate studies at Penn State University\, Dr. LaDuca earned his PhD in physiology from Roswell Park Cancer Institute in Buffalo\, NY. Dr. LaDuca completed his medical degree at SUNY at Syracuse. After completing an internship in Internal Medicine in Syracuse\, Dr. LaDuca completed his residency in Dermatology at The University of Rochester. It was during these years that Dr. LaDuca became interested in psoriasis and inflammatory skin conditions and was involved in clinical trials for some of the first biologic agents. Dr. LaDuca is the founder and managing partner of Reflections Dermatology and Psoriasis Center with three offices open in central New York. He continues to contribute to peer-reviewed journals\, teach residents\, medical and PA/NP students and lecture extensively about the use of biologics in dermatology. \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression. Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”\, where Jeffrey LaDuca\, MD will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data\, safety\, dosing information\, and how to get patients started on EBGLYSS. \nREGISTER HERE
URL:https://idefeducationalseries.com/event/explore-ebglysslebrikizumab-lbkz-see-how-ebglyss-can-leave-a-lasting-impression/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250828T190000
DTEND;TZID=UTC:20250828T200000
DTSTAMP:20260815T062616
CREATED:20250813T190412Z
LAST-MODIFIED:20250813T190412Z
UID:1660-1756407600-1756411200@idefeducationalseries.com
SUMMARY:Clearly Target RAR-y and the Lasting Marks of Acne
DESCRIPTION:Speaker: Catherine Papasakelariou\, MD President and CEO\, Houston Premier Dermatology\, Houston\, Texas \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Clearly Target RAR-y and the Lasting Marks of Acne. This presentation reviews the physical and emotional burdens of acne\, acne scarring\, and acne-induced hyperpigmentation. It highlights the unique and selective targeting of RAR-γ and reviews robust clinical data of this therapeutic approach\, while showcasing before and after images of successful patient outcomes. \n  \nREGISTER HERE
URL:https://idefeducationalseries.com/event/clearly-target-rar-y-and-the-lasting-marks-of-acne/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250826T190000
DTEND;TZID=UTC:20250826T200000
DTSTAMP:20260815T062616
CREATED:20250813T190234Z
LAST-MODIFIED:20250813T190234Z
UID:1658-1756234800-1756238400@idefeducationalseries.com
SUMMARY:The First Triple-Combination Topical for Acne ⏤ Breaking Ground in Treatment
DESCRIPTION:Speaker: Julie C. Harper\, MD\, FAAD The Dermatology and Skin Care Center of Birmingham Founding Director of the American Acne and Rosacea Society Birmingham\, Alabama \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nJoin us for another IDEF Educational Series Webinar: The First Triple-Combination Topical for Acne ⏤ Breaking Ground in Treatment. Attendees will have the opportunity to pose questions to the speaker about the data presented. This program is sponsored by Ortho Dermatologics and is being presented consistent with FDA guidelines and is not approved for continuing education credit. \n  \nREGISTER HERE
URL:https://idefeducationalseries.com/event/the-first-triple-combination-topical-for-acne-%e2%8f%a4-breaking-ground-in-treatment/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250820T190000
DTEND;TZID=UTC:20250820T200000
DTSTAMP:20260815T062616
CREATED:20250813T190114Z
LAST-MODIFIED:20250813T190114Z
UID:1656-1755716400-1755720000@idefeducationalseries.com
SUMMARY:What's Your BIO-Logical Next Step
DESCRIPTION:Speaker: Ted Lain\, MD\, MBA\, FAAD Founder & Medical Director Innovative Dermatology Clinical Associate Professor Department of Dermatology University of Texas Southwestern Medical Center \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: What’s Your BIO-Logical Next Step. Attendees will have the opportunity to pose questions to the speaker about the data presented. This program is sponsored by Ortho Dermatologics and is being presented consistent with FDA guidelines and is not approved for continuing education credit. \nREGISTER HERE
URL:https://idefeducationalseries.com/event/whats-your-bio-logical-next-step/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250819T190000
DTEND;TZID=UTC:20250819T200000
DTSTAMP:20260815T062616
CREATED:20250813T185927Z
LAST-MODIFIED:20250814T210954Z
UID:1653-1755630000-1755633600@idefeducationalseries.com
SUMMARY:Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK)
DESCRIPTION:Speaker: Jason Hawkes\, MD\, MS Clinical Assistant Professor of Dermatology\, Oregon Health & Science University Portland\, OR\n\n Moderator: Leon Kircik\, MD\, FAAD Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Adjunct Clinical Professor of Dermatology Indiana University School of Medicine\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY\n\n\nJoin us for another IDEF Educational Series Webinar: Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK) in Pathophysiology\, Unmet Needs\, and Disease Burden. This presentation offers a revealing look at chronic spontaneous urticaria (CSU)\, centered on two key aspects: the role of Bruton’s tyrosine kinase (BTK) as a mediator of FcεRI mast cell degranulation in its pathophysiology\, and the profound impact CSU symptoms can have on patients’ lives.\n\nREGISTER HERE
URL:https://idefeducationalseries.com/event/unlocking-chronic-spontaneous-urticaria-csu-exploring-the-role-of-brutons-tyrosine-kinase-btk/
END:VEVENT
END:VCALENDAR